BCM

BML Capital Management Portfolio holdings

AUM $131M
1-Year Return 89.45%
This Quarter Return
+17.68%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
+$22.7M
Cap. Flow
+$9.16M
Cap. Flow %
6.13%
Top 10 Hldgs %
80.92%
Holding
38
New
3
Increased
11
Reduced
6
Closed
4

Top Buys

1
ACRS icon
Aclaris Therapeutics
ACRS
$10.8M
2
ADVM icon
Adverum Biotechnologies
ADVM
$5.34M
3
TIL icon
Instil Bio
TIL
$3.77M
4
PMVP icon
PMV Pharmaceuticals
PMVP
$2.22M
5
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$1.43M

Top Sells

1
TRML icon
Tourmaline Bio
TRML
$6.43M
2
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$4.49M
3
RAIN
Rain Oncology Inc. Common Stock
RAIN
$1.62M
4
ATHA icon
Athira Pharma
ATHA
$1.52M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
$1.22M

Sector Composition

1 Healthcare 68.18%
2 Technology 1.32%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NXTC icon
26
NextCure
NXTC
$13.3M
$683K 0.45%
25,539
– –
CALC icon
27
CalciMedica
CALC
$44.6M
$667K 0.44%
160,424
+15,000
+10% +$62.4K
QTTB icon
28
Q32 Bio
QTTB
$20.9M
$424K 0.28%
24,894
-16,668
-40% -$284K
TLIS
29
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$374K 0.25%
42,743
– –
KLRS
30
Kalaris Therapeutics, Inc. Common Stock
KLRS
$82.1M
$151K 0.1%
+8,716
New +$151K
ANF icon
31
Abercrombie & Fitch
ANF
$4.39B
– –
0
– –
BBW icon
32
Build-A-Bear
BBW
$786M
– –
0
– –
NGNE icon
33
Neurogene
NGNE
$279M
– –
-24,666
Closed -$478K
QQQ icon
34
Invesco QQQ Trust
QQQ
$365B
– –
0
– –
TRML icon
35
Tourmaline Bio
TRML
$643M
– –
-245,500
Closed -$6.43M
WING icon
36
Wingstop
WING
$8.6B
– –
0
– –
THRX
37
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-1,108,320
Closed -$4.49M
RAIN
38
DELISTED
Rain Oncology Inc. Common Stock
RAIN
– –
-1,349,007
Closed -$1.62M
1
2